About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Category Archives: Useful Resources
Rx 4 Good
In today's environment there is a dichotomy for the pharmaceutical industry when it comes to good corporate social responsibility. Here it is. In the aggregate, the pharmaceutical and biotech industry actually provide a very very large contributions through philanthropy that … Continue reading
Posted in Useful Resources
1 Comment
FDA Presentation on Responses to 483s
What? What is a 483? A 483 is the vernacular for an FDA inspection of quality standards, manufacturing or the conduct of a clinical trial, and the discovery of deficiencies therein. In other words, theygo through your manufacturing facility, for … Continue reading
Posted in Crisis Communications, Useful Resources
Comments Off on FDA Presentation on Responses to 483s
Medpedia Launches! A Conversation with the Founder of Medpedia
For anyone in healthcare, there is a seismic shift that occurs today. It is the launch of Medpedia – a new Wiki created through the combined efforts of Havard Medical School, the Stanford Medical School, the University of California Berkely … Continue reading
Posted in New and Social Media, Useful Resources
1 Comment
The Changing Policy and Communications Environment and Implications for Pharma Marketing, Part 3
Here is the last of the 3-part series about the impact of expected upcoming changes in the policy environment and the tremendous migration in the communications environment and how this affects the marketing of pharmaceutical products. In this last installment, … Continue reading
Posted in Useful Resources
Comments Off on The Changing Policy and Communications Environment and Implications for Pharma Marketing, Part 3
The Changing Policy and Communications Environment and Implications for Pharma Marketing, Part 2
Today please find the second in a three-part series that looks at the changing policy and communications environments and the challenges and opportunities for pharmaceutical marketing. In Part 1 yesterday, what was covered was the fact that there is a … Continue reading
Posted in Useful Resources
Comments Off on The Changing Policy and Communications Environment and Implications for Pharma Marketing, Part 2